Showing results (121-130 of 5,644) with videos related to
Sort By:
Pageof 565
Drug Design, Development and Therapy|July 20, 2017
Targeted therapy in severe asthma today: focus on immunoglobulin EGirolamo Pelaia, Giorgio Walter Canonica, Andrea Matucci, et al.Drug Design, Development and Therapy|September 13, 2017
Advances in the delivery of buprenorphine for opioid dependenceRichard N Rosenthal, Viral V GoradiaDrug Design, Development and Therapy|June 18, 2016
The arsenal of pathogens and antivirulence therapeutic strategies for disarming themJohn R Brannon, Maria HadjifrangiskouDrug Design, Development and Therapy|March 26, 2016
Papaverine inhibits lipopolysaccharide-induced microglial activation by suppressing NF-κB signaling pathwayYalong Dang, Yalin Mu, Kun Wang, et al.Drug Design, Development and Therapy|March 30, 2016
Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritisMarco Krasselt, Christoph BaerwaldDrug Design, Development and Therapy|March 30, 2016
Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticityMichelle Kaku, David M SimpsonDrug Design, Development and Therapy|April 23, 2016
Clinicopathological significance and a potential drugtarget of RARβ in non-small-cell lung carcinoma: a meta-analysis and a systematic reviewXiaoyun Song, Kang Shi, Shi-Jie Zhou, et al.Drug Design, Development and Therapy|April 26, 2016
Acetogenins from Annona muricata as potential inhibitors of antiapoptotic proteins: a molecular modeling studyPriya Antony, Ranjit VijayanDrug Design, Development and Therapy|May 5, 2016
Zoledronate upregulates MMP-9 and -13 in rat vascular smooth muscle cells by inducing oxidative stressMehmet Zuhuri Arun, Buket Reel, Graciela B Sala-Newby, et al.Drug Design, Development and Therapy|May 5, 2016
Long-term efficacy and safety of oxycodone-naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase studyFabio Guerriero, Anna Roberto, Maria Teresa Greco, et al.Pageof 565